Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bacterial Infections and Mycoses

Free Subscription Articles published in Diagn Microbiol Infect Dis Retrieve available abstracts of 254 articles: HTML format

Single Articles

June 2024
1. ARYA K, Usmani SA, Bhardwaj N, Kumar M, et al
   Impact of sphingolipid synthesis inhibition on the drug susceptibility patterns of Trichophyton species.
   Diagn Microbiol Infect Dis. 2024;109:116283.
   PubMed     Abstract available
   
   
   
2. LAUPLAND KB, Edwards F, Harris PNA
   Proteus species bloodstream infections: Comparative epidemiology of three species.
   Diagn Microbiol Infect Dis. 2024;109:116286.
   PubMed     Abstract available
   
   
   
3. MONTE DFM, de Oliveira CJB
   Global distribution of colistin- and carbapenem-resistant Citrobacter freundii.
   Diagn Microbiol Infect Dis. 2024;109:116248.
   PubMed    
   
   
   
4. YILMAZ COLAK C
   Microfluidic point-of-care testing for the detection of Bordetella pertussis: A mini-review.
   Diagn Microbiol Infect Dis. 2024;109:116239.
   PubMed     Abstract available
   
   
   
5. HEINE L, Alfinete NW, Potgieter N, Barnard TG, et al
   Multi- and extensively drug resistant Escherichia coli isolated from South African children under 5 years old with diarrhoea.
   Diagn Microbiol Infect Dis. 2024;109:116279.
   PubMed     Abstract available
   
   
   
6. STEVENS MJA, Nuesch-Inderbinen M, Horlbog JA, Diethelm A, et al
   Sucrose-fermenting Salmonella Typhimurium N23-2364: a challenge for the diagnostic laboratory.
   Diagn Microbiol Infect Dis. 2024;109:116280.
   PubMed     Abstract available
   
   
   
7. CHERKAOUI S, Van den Wijngaert S, Dahma H, Martiny D, et al
   Letter to the editor about the strategy for performing treponemal tests in reverse-sequence algorithms of syphilis diagnosis: Establishment of a Threshold for Automated Treponemal Screening Tests using the Elecsys Syphilis Assay (Roche Diagnostics, Ma
   Diagn Microbiol Infect Dis. 2024;109:116267.
   PubMed    
   
   
   
8. NOURI R, Hasani A, Shirazi KM, Sefiadn FY, et al
   Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains.
   Diagn Microbiol Infect Dis. 2024;109:116229.
   PubMed     Abstract available
   
   
   
9. ROCA MORA MM, Cunha LM, Godoi A, Donadon I, et al
   Shorter versus longer duration of antimicrobial therapy for early Lyme disease: A systematic review and meta-analysis.
   Diagn Microbiol Infect Dis. 2024;109:116215.
   PubMed     Abstract available
   
   
   
10. BENNAI RM, Zouaki A, El Amin G, Rahani A, et al
    Pertussis outbreak in children hospitalized in Rabat (Morocco).
    Diagn Microbiol Infect Dis. 2024;109:116225.
    PubMed     Abstract available
    
    
    
11. A C, N C, A S, A P, et al
    Validation of a rapid molecular detection test for gram-negative multidrug-resistant bacteria in rectal swabs upon admission of patients to the intensive care unit.
    Diagn Microbiol Infect Dis. 2024;109:116250.
    PubMed     Abstract available
    
    
    
12. LEMOS-LUENGAS EV, Renteria-Valoyes S, Munoz DMA, Gonzalez CKG, et al
    In vitro activity of ceftazidime-avibactam against gram-negative bacteria in patients with bacteremia and skin and soft-tissue infections in Colombia 2019-2021.
    Diagn Microbiol Infect Dis. 2024;109:116235.
    PubMed     Abstract available
    
    
    May 2024
13. OZA Y, Patel R, Patel D, Shukla A, et al
    Taming Pseudomonas aeruginosa AM26 the barbarian: Targeting the PQS quorum sensing network using crude mandarin extract.
    Diagn Microbiol Infect Dis. 2024;109:116212.
    PubMed     Abstract available
    
    
    April 2024
14. GOURARI-BOUZOUINA K, Boucherit-Otmani Z, Seghir A, Baba Ahmed-Kazi Tani ZZ, et al
    Evaluation of mixed biofilm production by Candida spp. and Staphylococcus aureus strains co-isolated from cystic fibrosis patients in northwest Algeria.
    Diagn Microbiol Infect Dis. 2024;109:116321.
    PubMed     Abstract available
    
    
    
15. ZHOU Y, Zhang Y, Li L
    Identification of immune subtypes associated with neutrophils in tuberculosis infection based on weighted gene co-expression network analysis.
    Diagn Microbiol Infect Dis. 2024;109:116322.
    PubMed     Abstract available
    
    
    
16. BREGON-VILLAHOZ M, Menendez-Manjon P, Carrano G, Diez-Villalba A, et al
    Candida albicans cDNA library screening reveals novel potential diagnostic targets for invasive candidiasis.
    Diagn Microbiol Infect Dis. 2024;109:116311.
    PubMed     Abstract available
    
    
    
17. KHAMBATI N, Song R, Smith JP, Bijker EM, et al
    Feasibility and utility of a combined nasogastric-tube-and-string-test device for bacteriologic confirmation of pulmonary tuberculosis in young children.
    Diagn Microbiol Infect Dis. 2024;109:116302.
    PubMed     Abstract available
    
    
    
18. WANG C, Forsman LD, Wang S, Wang S, et al
    The diagnostic performance of GeneXpert MTB/RIF in tuberculosis meningitis: A multicentre accuracy study.
    Diagn Microbiol Infect Dis. 2024;109:116277.
    PubMed     Abstract available
    
    
    
19. SHEYKHSARAN E, Abbasi A, Memar MY, Ghotaslou R, et al
    The role of Staphylococcus aureus in cystic fibrosis pathogenesis and clinico-microbiological interactions.
    Diagn Microbiol Infect Dis. 2024;109:116294.
    PubMed     Abstract available
    
    
    
20. NOUE VV, Brasme L, Bajolet O, Legros V, et al
    Gardnerella vaginalis ventilatory acquired pneumonia among patients with trauma.
    Diagn Microbiol Infect Dis. 2024;108:116202.
    PubMed     Abstract available
    
    
    
21. CAVENESS CF, Orvin AI, Ingram CW, Bouchard JL, et al
    Impact of restrictive urinalysis reflex to culture criteria at a large community hospital.
    Diagn Microbiol Infect Dis. 2024;108:116183.
    PubMed     Abstract available
    
    
    
22. ZHANG S, Chen Z, Deng Z, Fu P, et al
    The value of calcofluor white in the diagnosis of invasive fungal diseases.
    Diagn Microbiol Infect Dis. 2024;108:116186.
    PubMed     Abstract available
    
    
    
23. PAUMIER M, Coussement J, Matignon M, Chauvet C, et al
    (1-3)-ss-D-glucan for the diagnosis of Nocardia infection in solid organ transplant recipients.
    Diagn Microbiol Infect Dis. 2024;108:116184.
    PubMed    
    
    
    
24. BLACKBERG A, Holm K, Liderot K, Nilson B, et al
    Eubacterium bacteremia - a retrospective observational study of a seldom found anaerobic pathogen.
    Diagn Microbiol Infect Dis. 2024;108:116185.
    PubMed     Abstract available
    
    
    March 2024
25. FERREIRA MAM, Pires PPA, Dos Santos KV
    Staphylococcus aureus nasal colonization and susceptibility profile to antimicrobials in hemodialysis patients using a protocol of seven collections.
    Diagn Microbiol Infect Dis. 2024;109:116295.
    PubMed     Abstract available
    
    
    
26. LI W, Huang Y, Tong S, Wan C, et al
    The characteristics of the gut microbiota in patients with pulmonary tuberculosis: A systematic review.
    Diagn Microbiol Infect Dis. 2024;109:116291.
    PubMed     Abstract available
    
    
    
27. COLAK AF, Yazar B, Bucaga TM, Demirel K, et al
    A rare case presentation of septic sacroiliitis caused by staphylococcus xylosus and complicated with abscess formation: A case report.
    Diagn Microbiol Infect Dis. 2024;109:116290.
    PubMed     Abstract available
    
    
    
28. DE SOUZA AC, Pereira DC, Barth PO, Roesch EW, et al
    Rapid identification,fluconazole and micafungin susceptibility testing of Candida species from blood culture by a short incubation method.
    Diagn Microbiol Infect Dis. 2024;109:116271.
    PubMed     Abstract available
    
    
    
29. ABOU MOURAD FERREIRA M, Candeias Dos Santos L, Schmidt Castellani LG, Negrelli Brunetti M, et al
    Application of BactTiter-Glo ATP bioluminescence assay for Mycobacterium tuberculosis detection.
    Diagn Microbiol Infect Dis. 2024;109:116275.
    PubMed     Abstract available
    
    
    
30. YING C, Zhang L, Jin X, Zhu D, et al
    Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Diagn Microbiol Infect Dis. 2024;109:116254.
    PubMed     Abstract available
    
    
    
31. CLOUTIER CHARETTE W, Rabodoarivelo MS, Point F, Knoblauch AM, et al
    Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
    Diagn Microbiol Infect Dis. 2024;109:116249.
    PubMed     Abstract available
    
    
    
32. O'MEARA KT, Chan JL, Ceron S, Lam JC, et al
    Polymerase chain reaction negative cryptococcal meningitis.
    Diagn Microbiol Infect Dis. 2024;109:116251.
    PubMed     Abstract available
    
    
    
33. ESFAHANI A, Omran AN, Salehi Z, Shams-Ghahfarokhi M, et al
    Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
    Diagn Microbiol Infect Dis. 2024;109:116242.
    PubMed     Abstract available
    
    
    
34. DOMINSKI BH, Raitz MF, Provenzi MA, Silveira ACO, et al
    Characterization of Methicillin-resistant Staphylococcus aureus (MRSA) isolated in Santa Catarina (SC), Brazil.
    Diagn Microbiol Infect Dis. 2024;109:116244.
    PubMed     Abstract available
    
    
    
35. LI G, Yu W, Ye Y, Han P, et al
    Postoperative mediastinitis and sternal osteitis after cardiac surgery caused by Mycoplasma hominis: A case report.
    Diagn Microbiol Infect Dis. 2024;108:116170.
    PubMed     Abstract available
    
    
    
36. FARFOUR E, Kitous C, Zucman D, Touche P, et al
    Comparison of the Alinity M STI with the GeneXpert CT/NG for the detection of sexually transmitted microorganisms.
    Diagn Microbiol Infect Dis. 2024;108:116179.
    PubMed     Abstract available
    
    
    
37. BIAN W, Shang Y, Zhao L, Wang K, et al
    Clinical performance of BALF droplet digital PCR for differential diagnosis of Pneumocystis jirovecii pneumonia and Pneumocystis jirovecii colonization.
    Diagn Microbiol Infect Dis. 2024;108:116168.
    PubMed     Abstract available
    
    
    February 2024
38. DAHL AL, Friis MB, Hallberg HW, Kristiansen GQ, et al
    Rapid detection of vanB vancomycin-resistant enterococci by laboratory-developed PCR on enrichment broth.
    Diagn Microbiol Infect Dis. 2024;109:116233.
    PubMed     Abstract available
    
    
    
39. NOOR AM, Ghazali SM, Bakar ZA, Ruzan IN, et al
    Diagnostic performance of Xpert MTB/RIF ultra in detecting Mycobacterium tuberculosis and Rifampicin Resistance in AFB Smear-negative Pulmonary and Extrapulmonary Tuberculosis samples in Malaysia.
    Diagn Microbiol Infect Dis. 2024;109:116230.
    PubMed     Abstract available
    
    
    
40. MAGRINI E, Rando E, Del Giacomo P, Matteini E, et al
    Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin.
    Diagn Microbiol Infect Dis. 2024;109:116205.
    PubMed     Abstract available
    
    
    
41. KOUPAEI M, Asadi A, Mahdizade Ari M, Seyyedi ZS, et al
    Secondary Klebsiella pneumoniae infection in patients with COVID-19: A systematic review.
    Diagn Microbiol Infect Dis. 2024;108:116105.
    PubMed     Abstract available
    
    
    
42. AMANN LF, Broeker A, Riedner M, Rohde H, et al
    Pharmacokinetic/pharmacodynamic evaluation of tigecycline dosing in a hollow fiber infection model against clinical bla-KPC producing Klebsiella Pneumoniae isolates.
    Diagn Microbiol Infect Dis. 2024;108:116153.
    PubMed     Abstract available
    
    
    
43. ZACHARIOUDAKIS IM, Zervou FN, Marsh K, Siegfried J, et al
    Utility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia.
    Diagn Microbiol Infect Dis. 2024;108:116107.
    PubMed     Abstract available
    
    
    
44. MALA R, Malhotra S, Singh N, Gupta S, et al
    Deciphering Intermediate Nugent scores: Utility of Real-time PCR for Bacterial Vaginosis diagnosis.
    Diagn Microbiol Infect Dis. 2024;108:116152.
    PubMed     Abstract available
    
    
    
45. WALKTY A, Karlowsky JA, Lagace-Wiens PRS, Baxter MR, et al
    Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2
    Diagn Microbiol Infect Dis. 2024;108:116130.
    PubMed     Abstract available
    
    
    
46. YAZDANPANAH S, Rahbarmah M, Motamedi M, Khodadadi H, et al
    Evaluation of the Performance of the Dynamiker Fungus (1-3)-beta-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation.
    Diagn Microbiol Infect Dis. 2024;108:116118.
    PubMed     Abstract available
    
    
    
47. ZHU L, Zhang H, Gu H, Zhou J, et al
    The pathology biopsy represents the "gold standard" for diagnosis: a case report.
    Diagn Microbiol Infect Dis. 2024;108:116138.
    PubMed     Abstract available
    
    
    
48. SANCHEZ D, Torres I, Padron C, Gimenez E, et al
    Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and lateral flow immunochromatography for rapid identification of beta-lactamase-gene-harboring Enterobacterales in urine specimens: Performance and cost-benefit analyses.
    Diagn Microbiol Infect Dis. 2024;108:116127.
    PubMed     Abstract available
    
    
    
49. PENG W, Deng R, Wu S, Zhao J, et al
    Increased rates of indeterminate results in QuantiFERON-TB gold in-tube during the COVID-19 epidemic in Hunan province, China.
    Diagn Microbiol Infect Dis. 2024;108:116131.
    PubMed     Abstract available
    
    
    January 2024
50. KIRMAIER A, Blackshear L, Lee MSL, Kirby JE, et al
    Cellulitis and bacteremia caused by the fish pathogen,Streptococcus iniae, in an immunocompromised patient: Case report and mini-review of zoonotic disease, lab identification, and antimicrobial susceptibility.
    Diagn Microbiol Infect Dis. 2024;108:116189.
    PubMed     Abstract available
    
    
    
51. ARENDS SJR, Butler D, Scangarella-Oman N, Castanheira M, et al
    Intermethod comparability analyses of gepotidacin antimicrobial susceptibility tests using a large collection of globally collected Escherichia coli and Staphylococcus saprophyticus clinical isolates.
    Diagn Microbiol Infect Dis. 2024;108:116181.
    PubMed     Abstract available
    
    
    
52. CHENG X, Ma L, Wang Y, Sun W, et al
    Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China.
    Diagn Microbiol Infect Dis. 2024;108:116180.
    PubMed     Abstract available
    
    
    
53. YAO S, Liu B, Hu X, Tan Y, et al
    Diagnostic value of microRNAs in active tuberculosis based on quantitative and enrichment analyses.
    Diagn Microbiol Infect Dis. 2024;108:116172.
    PubMed     Abstract available
    
    
    
54. HAIDER SI, Akhtar N, Saleem M, Ahmed S, et al
    Diagnosis of ''Helicobacter pylori infection of the gastric biopsy'' by rapid urease test, histopathology and Raman spectroscopy.
    Diagn Microbiol Infect Dis. 2024;108:116129.
    PubMed     Abstract available
    
    
    
55. DE SOUZA MQ, Bierhals DV, Reis AJ, Chimara E, et al
    2,3,5-triphenyl tetrazolium chloride as colorimetric indicator for drug susceptibility testing against nontuberculous mycobacteria.
    Diagn Microbiol Infect Dis. 2024;108:116096.
    PubMed     Abstract available
    
    
    
56. ULUSAN BAGCI O, Goksel O, Gumusburun R, Mert U, et al
    Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma.
    Diagn Microbiol Infect Dis. 2024;108:116124.
    PubMed     Abstract available
    
    
    
57. MOTALLEBIRAD T, Tashakor A, Abniki R, Azadi D, et al
    Fifteen years of phenotypic and genotypic surveillance and antibiotic susceptibility pattern of Actinomycetes (Mycobacterium, Nocardia, Rhodococcus, etc.) in clinical and environmental samples of Iran.
    Diagn Microbiol Infect Dis. 2024;108:116080.
    PubMed     Abstract available
    
    
    
58. LI X, Li D, Han D
    Rapid diagnosis of Aspergillus fumigatus endocarditis using mNGS assay: A case report and review of the literature.
    Diagn Microbiol Infect Dis. 2024;108:116171.
    PubMed     Abstract available
    
    
    December 2023
59. GUAN Y, Ma X, Sun X, Zhang H, et al
    Metagenomic next-generation sequencing on bronchoalveolar lavage fluid to contribute to diagnosis of subclinical pulmonary tuberculosis with scarce sputum and negative smear in a patient mimicking adult- onset still's disease: A case report.
    Diagn Microbiol Infect Dis. 2023;108:116165.
    PubMed     Abstract available
    
    
    
60. JAIN P, Ratnam R, Sengupta S, Singh U, et al
    High frequency of isoniazid and fluroquinolone resistance among patients with rifampicin sensitive tuberculosis.
    Diagn Microbiol Infect Dis. 2023;108:116159.
    PubMed     Abstract available
    
    
    
61. GUO G, Tuohetaerbaike B, Wu X, Zhang Y, et al
    Serological investigation of brucella infection using a dipstick assay among individuals with unexplained fever in farming-pastoral areas of Xinjiang, China.
    Diagn Microbiol Infect Dis. 2023;107:116079.
    PubMed     Abstract available
    
    
    
62. DESTACHE CJ, Boldt D, Anthone J, Velagapudi M, et al
    Assessment of the impact of centralized bioMerieux BACT/ALERT(R) VIRTUO(R) blood culture system (VIRTUO) implementation on outcomes in patients with gram-negative bacteremia.
    Diagn Microbiol Infect Dis. 2023;107:116085.
    PubMed     Abstract available
    
    
    
63. LIU X, Bao X, Gao L, Li G, et al
    Comparative application of droplet-based digital and quantitative real-time PCR for human brucellosis detection.
    Diagn Microbiol Infect Dis. 2023;107:116087.
    PubMed     Abstract available
    
    
    
64. BRADFORD WS, Donnelley MA, Fine JR, Crabtree SJ, et al
    Blood culture identification (BCID) performance in polymicrobial bacteremia.
    Diagn Microbiol Infect Dis. 2023;107:116086.
    PubMed     Abstract available
    
    
    
65. GANDHI K, Wrzesinski M, Bunnell K, Gibble A, et al
    Oral antibiotic step-down therapy for nonstaphylococcal gram-positive bloodstream infections.
    Diagn Microbiol Infect Dis. 2023;107:116068.
    PubMed     Abstract available
    
    
    
66. ISKENDER S, Heydarov S, Yalcin M, Faydaci C, et al
    Rapid determination of colistin resistance in Klebsiella pneumoniae by MALDI-TOF peak based machine learning algorithm with MATLAB.
    Diagn Microbiol Infect Dis. 2023;107:116052.
    PubMed     Abstract available
    
    
    
67. ZHANG Y, Hai Y, Duan B, Long H, et al
    A seminested recombinase polymerase amplification assay to detect rickettsial pathogens in clinical samples.
    Diagn Microbiol Infect Dis. 2023;107:116067.
    PubMed     Abstract available
    
    
    
68. SILVA CMD, Juca MB, Melo ASA, Lima SL, et al
    Neonatal fungemia caused by Lodderomyces elongisporus: first case report in Latin America.
    Diagn Microbiol Infect Dis. 2023;107:116077.
    PubMed     Abstract available
    
    
    
69. BOYANOVA L, Boyanova L, Hadzhiyski P, Kandilarov N, et al
    Mixed (multiple-genotype) Helicobacter pylori infections in Bulgarian patients.
    Diagn Microbiol Infect Dis. 2023;107:116073.
    PubMed     Abstract available
    
    
    
70. CHONG E, Kang M, Choi H, Yun SA, et al
    Comparison of the STANDARD F and SD BIOLINE stool antigen tests for diagnosis of Helicobacter pylori infection.
    Diagn Microbiol Infect Dis. 2023;107:116051.
    PubMed     Abstract available
    
    
    November 2023
71. CORREIA JL, Fiuza JG, Ferreira G, Almeida MD, et al
    Embolic stroke and misidentification candida species endocarditis: Case presentation and literature review.
    Diagn Microbiol Infect Dis. 2023;108:116133.
    PubMed     Abstract available
    
    
    
72. ROWE AS, Hawkins B, McClam MD, Winters S, et al
    Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumonia.
    Diagn Microbiol Infect Dis. 2023;108:116134.
    PubMed     Abstract available
    
    
    
73. LIU RT, Zhang D, Li S, Chen Y, et al
    Comparison of different criteria of metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in critically ill patients.
    Diagn Microbiol Infect Dis. 2023;108:116135.
    PubMed     Abstract available
    
    
    
74. CEPEDA JG, Perona FL, Sanchez IB, Calvo JC, et al
    Case report: Prosthetic aortic valve endocarditis due to Staphylococcus epidermidis with acquired resistance in the walK gene.
    Diagn Microbiol Infect Dis. 2023;108:116132.
    PubMed     Abstract available
    
    
    
75. YU M, Zhang C, Xu L, Peng K, et al
    Comparison of the MeltPro TB assay and whole-genome sequencing assay for rapid molecular diagnosis of drug resistant tuberculosis in guangdong province.
    Diagn Microbiol Infect Dis. 2023;108:116128.
    PubMed     Abstract available
    
    
    
76. YANG H, Du R, Xing X, Li Y, et al
    Efficacy and influencing factor analysis of Voriconazole in the treatment of invasive fungal infections.
    Diagn Microbiol Infect Dis. 2023;107:116047.
    PubMed     Abstract available
    
    
    
77. PUMEESAT P, Wongsuk T
    Genetic analysis of emerging fungal pathogens: Trichosporon asahii.
    Diagn Microbiol Infect Dis. 2023;107:116057.
    PubMed     Abstract available
    
    
    
78. GASTALDI GUERRIERI C, Teixeira Goncalves M, Ferreira da Silva A, Souza Dos Santos AL, et al
    Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro.
    Diagn Microbiol Infect Dis. 2023;107:116048.
    PubMed     Abstract available
    
    
    
79. DIXIT R, Gopalan N, Behera SK
    Isothermal amplification technology (IAT) for rapid diagnosis of Rickettsioses: scope, overview, existing evidence, and the way forward.
    Diagn Microbiol Infect Dis. 2023;107:116046.
    PubMed     Abstract available
    
    
    
80. CUHACI U, Caglar K
    Establishment of a method to detect human immunoglobulin G1 binding microorganisms.
    Diagn Microbiol Infect Dis. 2023;107:116019.
    PubMed     Abstract available
    
    
    
81. YAN D, Sun M, Xiao L, Chen H, et al
    Interspecies interactions of non-O1/O139 Vibrio cholerae and Salmonella typhimurium: a rare coinfection case report.
    Diagn Microbiol Infect Dis. 2023;107:116049.
    PubMed     Abstract available
    
    
    October 2023
82. CHANG M, Venkatasubramanian S, Barrett H, Urdahl KB, et al
    Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guerin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine development.
    Diagn Microbiol Infect Dis. 2023;108:116106.
    PubMed     Abstract available
    
    
    
83. AHMAD S, Rahman H, Mumtaz S, Qasim M, et al
    mecA and fdh: markers of pathogenicity and commensalism in Staphylococcus epidermidis of pediatric origin from Pakistan.
    Diagn Microbiol Infect Dis. 2023;108:116109.
    PubMed     Abstract available
    
    
    
84. DWIVEDI H, MacDonald K, Angaali N, Garrett S, et al
    Multicenter matched-pair study comparing BACT/ALERT(R) MP reagent systems for the recovery of mycobacteria from specimens other than blood.
    Diagn Microbiol Infect Dis. 2023;107:115959.
    PubMed     Abstract available
    
    
    
85. ITO Y, Kaneko N, Yoshida M, Nakayama H, et al
    Evaluation of a novel Clostridioides difficile-selective growth broth under aerobic conditions.
    Diagn Microbiol Infect Dis. 2023;107:116020.
    PubMed     Abstract available
    
    
    
86. BEDAN M, Gloksin W, Hagen TL
    Lemierre's syndrome-A diagnostic challenge.
    Diagn Microbiol Infect Dis. 2023;107:116023.
    PubMed     Abstract available
    
    
    
87. FAZIO A, Bitran-Ambler M, Ramirez-Rivera S, Zaffiri V, et al
    Genotyping of Helicobacter pylori CagA/CagE strains in gastric mucosa and its association with gastric illness.
    Diagn Microbiol Infect Dis. 2023;107:116028.
    PubMed     Abstract available
    
    
    
88. BROERTJES J, Jansen R, Verly I, van der Zwaluw K, et al
    Typhoid fever due to laboratory-acquired Salmonella Typhi, confirmed by core genome multi-locus sequence typing.
    Diagn Microbiol Infect Dis. 2023;107:116016.
    PubMed     Abstract available
    
    
    
89. VAHIDNIA A, Voll S, Zwart N, Tangali F, et al
    Development and validation of a fully automated laboratory-developed test for detection of HSV-1/2 and VZV in clinical samples run on the Panther Fusion(R) system.
    Diagn Microbiol Infect Dis. 2023;107:116022.
    PubMed     Abstract available
    
    
    
90. SMITH RD, Johnson JK, Ernst RK
    Comparison of 3 diagnostic platforms for identification of bacteria and yeast from positive blood culture bottles.
    Diagn Microbiol Infect Dis. 2023;107:116018.
    PubMed     Abstract available
    
    
    September 2023
91. MARTINS DM, Cardoso EM, Capellari L, Botelho LAB, et al
    Detection of Staphylococcus aureus from nares of elderly living in a Brazilian nursing home.
    Diagn Microbiol Infect Dis. 2023;108:116089.
    PubMed     Abstract available
    
    
    
92. AGRAWAL P, Upadhyay A, Kumar A
    microRNA as biomarkers in tuberculosis: a new emerging molecular diagnostic solution.
    Diagn Microbiol Infect Dis. 2023;108:116082.
    PubMed     Abstract available
    
    
    
93. ZOU X, Zhu Y, Qin Y, Fei F, et al
    Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis.
    Diagn Microbiol Infect Dis. 2023;107:115921.
    PubMed     Abstract available
    
    
    
94. FARFOUR E, Clichet V, Pean de Ponfilly G, Carbonnelle E, et al
    Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology.
    Diagn Microbiol Infect Dis. 2023;107:116002.
    PubMed     Abstract available
    
    
    August 2023
95. SORDO M, Grilo T, Freire S, Rodrigues B, et al
    Rapid culture-based LNZ test for detection of linezolid susceptibility/resistance in staphylococci and enterococci.
    Diagn Microbiol Infect Dis. 2023;107:116058.
    PubMed     Abstract available
    
    
    
96. CAZA M, Charles M, Locher K, Hoang L, et al
    Evaluation of the Aptima BV and CV/TV assays compared to conventional laboratory based testing methods for the diagnosis of vaginitis.
    Diagn Microbiol Infect Dis. 2023;106:115953.
    PubMed     Abstract available
    
    
    
97. GREEN OJ, Ganim RB, Mueller JD
    A case of diffuse panbronchiolitis caused by Mycoplasma amphoriforme.
    Diagn Microbiol Infect Dis. 2023;106:115990.
    PubMed     Abstract available
    
    
    
98. HU Y, Zhu Y, Li C, Shi H, et al
    Evaluation of BACTEC MGIT 960 system for recovery of Nocardia from clinical specimens.
    Diagn Microbiol Infect Dis. 2023;106:115989.
    PubMed     Abstract available
    
    
    
99. LIU Y, Ma L, Sun W, Cheng J, et al
    Molecular epidemiology, antimicrobial susceptibility, and toxin production of clinical Clostridioides difficile isolates from a teaching hospital in Northern China.
    Diagn Microbiol Infect Dis. 2023;106:115972.
    PubMed     Abstract available
    
    
    July 2023
100. OBERG J, Inghammar M, Nilson B
     Improved identification of Streptococcus bovis-Streptococcus equinus-complex species and subspecies by MALDI-TOF MS using a novel library.
     Diagn Microbiol Infect Dis. 2023;107:116045.
     PubMed     Abstract available
     
     
     
101. GARCIA-SANCHEZ C, Bloise I, Garcia-Rodriguez J, Cendejas-Bueno E, et al
     Are cerebrospinal fluid biochemical parameters valid to predict positive results in microbiological molecular diagnostic platforms? A 4-year experience with the FilmArray(R) Panel Meningitis/Encephalitis for detection of community-acquired bacterial m
     Diagn Microbiol Infect Dis. 2023;107:116031.
     PubMed     Abstract available
     
     
     
102. LIN Y, Zhang W, Xiong Y, Wang Y, et al
     Comparative performance of microbiological methods for the detection of tuberculous meningitis pathogens in cerebrospinal fluid.
     Diagn Microbiol Infect Dis. 2023;107:116025.
     PubMed     Abstract available
     
     
     
103. PALUCH M, Lleres-Vadeboin M, Poupet H, Chanard E, et al
     Multicenter evaluation of rapid antimicrobial susceptibility testing by VITEK(R)2 directly from positive blood culture.
     Diagn Microbiol Infect Dis. 2023;106:115950.
     PubMed     Abstract available
     
     
     
104. YUAN L, Xia D, Zhou Q, Xu W, et al
     An evaluation of a multiplex PCR assay for the detection of Treponema pallidum, HSV-1, and HSV-2.
     Diagn Microbiol Infect Dis. 2023;106:115958.
     PubMed     Abstract available
     
     
     
105. ZHU Q, Xu J, Chen X, Ren Y, et al
     Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
     Diagn Microbiol Infect Dis. 2023;106:115955.
     PubMed     Abstract available
     
     
     
106. ARSLAN E, Coskun MK, Cobanoglu S, Aslan MH, et al
     Effects of four antibiotics on Pseudomonas aeruginosa motility, biofilm formation, and biofilm-specific antibiotic resistance genes expression.
     Diagn Microbiol Infect Dis. 2023;106:115931.
     PubMed     Abstract available
     
     
     June 2023
107. KAZANCIOGLU S, Bastug A, Ozbay BO, Tezcan H, et al
     The usefulness of hematological parameters and cerebrospinal fluid indexes in the differential diagnosis of acute bacterial from viral meningitis.
     Diagn Microbiol Infect Dis. 2023;107:116005.
     PubMed     Abstract available
     
     
     
108. BENAHMED A, Seghir A, Boucherit-Otmani Z, Tani ZZBA, et al
     In vitro evaluation of biofilm formation by Candida parapsilosis and Enterobacter cloacae. Scanning electron microscopy and efficacy of antimicrobial combinations study.
     Diagn Microbiol Infect Dis. 2023;107:116003.
     PubMed     Abstract available
     
     
     
109. MATHIASEN ASF, Bigum LH, Andreassen KH, Slotved HC, et al
     Haemophilus influenzae septicaemia and urinary tract infection associated with nefrocalcinosis: case report.
     Diagn Microbiol Infect Dis. 2023;107:116001.
     PubMed     Abstract available
     
     
     
110. WANG Y, Zhang M, Huang M, Wang T, et al
     Detection of serum human neutrophil lipocalin is an effective biomarker for the diagnosis and monitoring of children with bacterial infection.
     Diagn Microbiol Infect Dis. 2023;106:115943.
     PubMed     Abstract available
     
     
     
111. MABUGANA MC, Dias BDC, Muller EE, Kufa T, et al
     The evaluation of the Allplex BV molecular assay for the diagnosis of bacterial vaginosis in symptomatic South African females.
     Diagn Microbiol Infect Dis. 2023;106:115924.
     PubMed     Abstract available
     
     
     
112. BARROSO MDV, da Silva CR, Benfatti LR, Gozi KS, et al
     Characterization of KPC-2-producing Klebsiella pneumoniae and affected patients of a pediatric hospital in Brazil.
     Diagn Microbiol Infect Dis. 2023;106:115932.
     PubMed     Abstract available
     
     
     
113. AREND LNVS, Bergamo R, Rocha FB, Bail L, et al
     Dissemination of NDM-producing bacteria in Southern Brazil.
     Diagn Microbiol Infect Dis. 2023;106:115930.
     PubMed     Abstract available
     
     
     
114. GAO L, Yang T, Zhang X, Lei W, et al
     Rapid detection of pulmonary nocardiosis by metagenomic next generation sequencing.
     Diagn Microbiol Infect Dis. 2023;106:115928.
     PubMed     Abstract available
     
     
     May 2023
115. DASS M, Kaur M, Aittan S, Sharma P, et al
     MPT51 and MPT64-based antigen detection assay for the diagnosis of extrapulmonary tuberculosis from urine samples.
     Diagn Microbiol Infect Dis. 2023;107:115973.
     PubMed     Abstract available
     
     
     
116. OBENG-NKRUMAH N, Hansen DS, Awuah-Mensah G, Blankson NK, et al
     High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana.
     Diagn Microbiol Infect Dis. 2023;106:115918.
     PubMed     Abstract available
     
     
     
117. ZELLNER AA, Hischebeth GT, Molitor E, Wirtz DC, et al
     Periprosthetic joint infection caused by kytococcus schroeteri: The first reported case and a review of the literature.
     Diagn Microbiol Infect Dis. 2023;106:115922.
     PubMed     Abstract available
     
     
     April 2023
118. HUBLER CM, Carvalhaes CG, Castanheira M
     Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method for this alteration.
     Diagn Microbiol Infect Dis. 2023;106:115957.
     PubMed     Abstract available
     
     
     
119. KANWAR N, Harrison CJ, Pence MA, Qin X, et al
     Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis.
     Diagn Microbiol Infect Dis. 2023;105:115904.
     PubMed     Abstract available
     
     
     
120. SAFI AUR, Bendixen E, Rahman H, Khattak B, et al
     Molecular identification and differential proteomics of drug resistant Salmonella Typhi.
     Diagn Microbiol Infect Dis. 2023;105:115883.
     PubMed     Abstract available
     
     
     
121. DE BEL A, Brouwers A, Verbeke F, Coorevits L, et al
     VIDAS3(R) TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence population.
     Diagn Microbiol Infect Dis. 2023;105:115885.
     PubMed     Abstract available
     
     
     March 2023
122. DAFFINEE KE, O'Neill ET, Bleick CR, Williams G, et al
     Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin.
     Diagn Microbiol Infect Dis. 2023;106:115947.
     PubMed     Abstract available
     
     
     
123. KOETH LM, DiFranco-Fisher JM, Scangarella-Oman NE
     Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus.
     Diagn Microbiol Infect Dis. 2023;106:115946.
     PubMed     Abstract available
     
     
     
124. ZHENG M, Wang Y, Ying X, Zhang P, et al
     Clinical utility of tuberculosis RNA in the rapid diagnosis of bone and joint tuberculosis.
     Diagn Microbiol Infect Dis. 2023;106:115941.
     PubMed     Abstract available
     
     
     
125. GAVAZZI G, Meyrignac L, Zerhouni N, Bioteau C, et al
     Intrinsic values of procalcitonin in bacterial bloodstream infections in people aged 75 years and over: a retrospective study.
     Diagn Microbiol Infect Dis. 2023;105:115887.
     PubMed     Abstract available
     
     
     
126. HUNKINS JJ, de-Moura VC, Eddy JJ, Daley CL, et al
     In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States.
     Diagn Microbiol Infect Dis. 2023;105:115882.
     PubMed     Abstract available
     
     
     
127. HURT W, Stephenson J, Hutchinson J, Godbole G, et al
     A rare case of Salmonella Paratyphi C osteomyelitis: A genetic analysis and review of Salmonella osteomyelitis in England.
     Diagn Microbiol Infect Dis. 2023;105:115877.
     PubMed     Abstract available
     
     
     
128. BAKTHAVATCHALAM YD, Basu S, Shankar A, Ramaiah S, et al
     Genomics and structural insight into the masking of gentamicin-resistance in clinical Burkholderia pseudomallei strain VB29710 from India.
     Diagn Microbiol Infect Dis. 2023;105:115878.
     PubMed     Abstract available
     
     
     February 2023
129. ARMSTRONG D, Fisher S, Totten M, Parrish N, et al
     An analytic feasibility study of the BD MAX MDR-TB assay for testing of non-sputum specimens for detection of the Mycobacterium tuberculosis complex (MTBC) and isoniazid (INH) and rifampin (RIF) resistance.
     Diagn Microbiol Infect Dis. 2023;106:115925.
     PubMed     Abstract available
     
     
     
130. MUNIER C, Dupieux C, Kolenda C, Ranc AG, et al
     Sensitivity of the PBP2a SA Culture Colony Test on shortly incubated subcultures of methicillin-resistant staphylococci from positive blood cultures.
     Diagn Microbiol Infect Dis. 2023;106:115917.
     PubMed     Abstract available
     
     
     
131. SILVA NC, de Souza MC, Tonini MAL, Schuenck RP, et al
     Dissemination of methicillin-resistant Staphylococcus aureus USA300 ST8/PVL- positive in breast infections in a Brazilian region.
     Diagn Microbiol Infect Dis. 2023;106:115919.
     PubMed     Abstract available
     
     
     
132. KUCUKOGLU O, Sariguzel FM, Koc AN, Parkan OM, et al
     Molecular epidemiology, virulence factors, and antifungal susceptibility of Candida inconspicua strains isolated from clinical samples in Turkey.
     Diagn Microbiol Infect Dis. 2023;106:115915.
     PubMed     Abstract available
     
     
     
133. FLORES-VEGA VR, Lara-Zavala BA, Jarillo-Quijada MD, Fernandez-Vazquez JL, et al
     Burkholderia vietnamiensis causing infections in noncystic fibrosis patients in a tertiary care hospital in Mexico.
     Diagn Microbiol Infect Dis. 2023;105:115866.
     PubMed     Abstract available
     
     
     
134. SU W, Ju L, Hua Q, Hu J, et al
     Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children.
     Diagn Microbiol Infect Dis. 2023;105:115865.
     PubMed     Abstract available
     
     
     
135. FREIRE S, Grilo T, Nordmann P, Poirel L, et al
     Multiplex PCR for detection of acquired plasmid-borne fosfomycin resistance fos genes in Escherichia coli.
     Diagn Microbiol Infect Dis. 2023;105:115864.
     PubMed     Abstract available
     
     
     
136. LAROCHE L, Mercier V, Sasso M
     BD BACTEC Mycosis IC/F culture vials for fungemia diagnosis and follow-up: a retrospective study from 2013 to 2020.
     Diagn Microbiol Infect Dis. 2023;105:115863.
     PubMed     Abstract available
     
     
     
137. MIENDJE DEYI VY, Ntounda R, Louis H, Kahegeshe NL, et al
     Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
     Diagn Microbiol Infect Dis. 2023;105:115855.
     PubMed     Abstract available
     
     
     
138. DONNARS A, Mahieu R, Declerck C, Chenouard R, et al
     BIOFIRE(R) Blood Culture IDentification 2 (BCID2) panel for early adaptation of antimicrobial therapy in adult patients with bloodstream infections: a real-life experience.
     Diagn Microbiol Infect Dis. 2023;105:115858.
     PubMed     Abstract available
     
     
     
139. LI L, Yuan Y, He W, Zheng L, et al
     Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China.
     Diagn Microbiol Infect Dis. 2023;105:115854.
     PubMed     Abstract available
     
     
     
140. KRAUSSER L, Braet SM, Benaamar Z, Van Dyck-Lippens M, et al
     Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield.
     Diagn Microbiol Infect Dis. 2023;106:115905.
     PubMed     Abstract available
     
     
     January 2023
141. LUO Y, Xue Y, Liu W, Song H, et al
     Convolutional neural network based on T-SPOT.TB assay promoting the discrimination between active tuberculosis and latent tuberculosis infection.
     Diagn Microbiol Infect Dis. 2023;105:115892.
     PubMed     Abstract available
     
     
     
142. BRUNING AHL, Beld MVD, Laverge J, Welkers MRA, et al
     Reptile-associated Salmonella urinary tract infection: a case report.
     Diagn Microbiol Infect Dis. 2023;105:115889.
     PubMed     Abstract available
     
     
     
143. SABIN AP, Scholze BP, Lovrich SD, Callister SM, et al
     Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
     Diagn Microbiol Infect Dis. 2023;105:115837.
     PubMed     Abstract available
     
     
     
144. LEWIS AD, Bridwell MR, Hambuchen MD, Clay TB, et al
     Correlation of MRSA polymerase chain reaction (PCR) nasal swab in ventilator-associated pneumonia, lung abscess, and empyema.
     Diagn Microbiol Infect Dis. 2023;105:115836.
     PubMed     Abstract available
     
     
     
145. ARISTIZABAL-HOYOS AM, Rodriguez EA, Torres-Palma RA, Jimenez JN, et al
     Concern levels of beta-lactamase-producing Gram-negative bacilli in hospital wastewater: hotspot of antimicrobial resistance in Latin-America.
     Diagn Microbiol Infect Dis. 2023;105:115819.
     PubMed     Abstract available
     
     
     December 2022
146. GOTO R, Jin W, Wachino JI, Arakawa Y, et al
     Improved disk diffusion method for simple detection of group B streptococci with reduced penicillin susceptibility (PRGBS).
     Diagn Microbiol Infect Dis. 2022;105:115881.
     PubMed     Abstract available
     
     
     
147. SOOD M, Sharma S, Sood S, Sharma V, et al
     Diagnostic accuracy of urine based lipoarabinomannan point of care tuberculosis diagnostic test in HIV negative children: a systematic review and meta-analysis.
     Diagn Microbiol Infect Dis. 2022;105:115879.
     PubMed     Abstract available
     
     
     
148. TSUNEOKA H, Otsuyama KI, Hirano A, Nojima J, et al
     Clinical utility of indirect fluorescent assay for IgA class antibodies against Bartonella henselae in serodiagnosis of cat scratch disease in its early stage.
     Diagn Microbiol Infect Dis. 2022;104:115809.
     PubMed     Abstract available
     
     
     
149. SANCHEZ NO, Perez NF, Martinez SB
     Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
     Diagn Microbiol Infect Dis. 2022;104:115798.
     PubMed     Abstract available
     
     
     
150. HUANG HY, Chang YT, Lu PL, Yang TY, et al
     Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
     Diagn Microbiol Infect Dis. 2022;104:115799.
     PubMed     Abstract available
     
     
     
151. PFALLER M, Mendes RE, Streit JM, Carvalhaes CG, et al
     Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019).
     Diagn Microbiol Infect Dis. 2022;104:115804.
     PubMed     Abstract available
     
     
     
152. GARCIA-RIVERA C, Parra-Grande M, Merino E, Boix V, et al
     Concordance of the filmarray blood culture identification panel 2 and classical microbiological methods in a bacteriemia diagnostic unit.
     Diagn Microbiol Infect Dis. 2022;104:115787.
     PubMed     Abstract available
     
     
     
153. XIA D, Yuan L, Zhou Q, Chen S, et al
     Performance evaluation of eight treponemal antibody tests in China.
     Diagn Microbiol Infect Dis. 2022;104:115790.
     PubMed     Abstract available
     
     
     
154. KUO P, LeCrone K, Chiu M, Realegeno S, et al
     Analysis of the FAST system for expedited identification and antimicrobial susceptibility testing of bloodborne pathogens.
     Diagn Microbiol Infect Dis. 2022;104:115783.
     PubMed     Abstract available
     
     
     November 2022
155. PINHATA JMW, Brandao AP, Gallo JF, Oliveira RS, et al
     GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
     Diagn Microbiol Infect Dis. 2022;105:115856.
     PubMed     Abstract available
     
     
     
156. LEROY AG, Robert M, Carpentier M, Bastidon C, et al
     Assessment of a fully automated RPR assay (Mediace RPR) for serological diagnosis and follow-up of syphilis: a retrospective study.
     Diagn Microbiol Infect Dis. 2022;104:115767.
     PubMed     Abstract available
     
     
     
157. BALLABEN AS, Galetti R, Ferreira JC, Paziani MH, et al
     Different virulence genetic context of multidrug-resistant CTX-M- and KPC-producing Klebsiella pneumoniae isolated from cerebrospinal fluid.
     Diagn Microbiol Infect Dis. 2022;104:115784.
     PubMed     Abstract available
     
     
     
158. MCCARTY TP, White CM, Meeder J, Moates D, et al
     Analytical performance and potential clinical utility of the GenMark Dx ePlex(R) blood culture identification gram-positive panel.
     Diagn Microbiol Infect Dis. 2022;104:115762.
     PubMed     Abstract available
     
     
     
159. YOSHIDA S, Tsuyuguchi K, Kobayashi T, Shimatani Y, et al
     Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type.
     Diagn Microbiol Infect Dis. 2022;104:115773.
     PubMed     Abstract available
     
     
     
160. PIETIKAINEN A, Glader O, Kortela E, Kanerva M, et al
     Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis.
     Diagn Microbiol Infect Dis. 2022;104:115782.
     PubMed     Abstract available
     
     
     October 2022
161. SASAKI T, Doi Y
     Staphylococcus lugdunensis bacteremia: clinical implications of single set positive blood cultures.
     Diagn Microbiol Infect Dis. 2022;105:115835.
     PubMed     Abstract available
     
     
     
162. LIM YK, Kweon OJ, Kim HR, Kim TH, et al
     Comparison of simulated candidemia detection during prophylactic antifungal therapy.
     Diagn Microbiol Infect Dis. 2022;104:115768.
     PubMed     Abstract available
     
     
     
163. PRUSSING C, Southwick K, Snavely E, Kidney A, et al
     Comparative analysis of multiplexed PCR and short- and long-read whole genome sequencing to investigate a large Klebsiella pneumoniae outbreak in New York State.
     Diagn Microbiol Infect Dis. 2022;104:115765.
     PubMed     Abstract available
     
     
     
164. ZHAO J, Lu B, Zhou Y, Wang S, et al
     Molecular identification and clinical significance of Mycobacterium seoulense strains from patients with nontuberculous mycobacterium infections.
     Diagn Microbiol Infect Dis. 2022;104:115756.
     PubMed     Abstract available
     
     
     
165. MENTULA S, Paakkanen J, Hyyrylainen HL
     External quality assessment by European mycobacterial laboratories: results of AFB microscopy and identification rounds.
     Diagn Microbiol Infect Dis. 2022;104:115757.
     PubMed     Abstract available
     
     
     September 2022
166. SADER HS, Castanheira M, Duncan LR, Mendes RE, et al
     Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020).
     Diagn Microbiol Infect Dis. 2022;105:115820.
     PubMed     Abstract available
     
     
     
167. KHRULNOVA S, Fedorova A, Frolova I, Tandilova K, et al
     Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies.
     Diagn Microbiol Infect Dis. 2022;104:115744.
     PubMed     Abstract available
     
     
     
168. BOYANOVA L, Kandilarov N, Hadzhiyski P, Gergova R, et al
     Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.
     Diagn Microbiol Infect Dis. 2022;104:115746.
     PubMed     Abstract available
     
     
     
169. DURSKI M, Ravel J, Spautz ACPG, Carvalho NS, et al
     Comparison of two microscopic interpretations of vaginal microbiota with molecular profiling.
     Diagn Microbiol Infect Dis. 2022;104:115728.
     PubMed     Abstract available
     
     
     August 2022
170. GO JR, Baddour LM, Lahr BD, Sohail MR, et al
     The skip phenomenon in Staphylococcus aureus bacteremia: clinical implications.
     Diagn Microbiol Infect Dis. 2022;104:115802.
     PubMed     Abstract available
     
     
     
171. ARONIN SI, Dunne MW, Yu KC, Watts JA, et al
     Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 - 2020.
     Diagn Microbiol Infect Dis. 2022;103:115717.
     PubMed     Abstract available
     
     
     
172. COWMAN K, Rossi J, Gendlina I, Guo Y, et al
     Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
     Diagn Microbiol Infect Dis. 2022;103:115721.
     PubMed     Abstract available
     
     
     July 2022
173. LAUPLAND KB, Harris PNA, Stewart AG, Edwards F, et al
     Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.
     Diagn Microbiol Infect Dis. 2022;104:115772.
     PubMed     Abstract available
     
     
     
174. DAHAN NASSY S, Azrad M, Abozaid S, Glikman D, et al
     Assessing the impact of a positive Biofire(R) FilmArray(R) Meningitis/Encephalitis Panel result on clinical management and outcomes.
     Diagn Microbiol Infect Dis. 2022;104:115769.
     PubMed     Abstract available
     
     
     
175. BRIDWELL MR, Bajaj S, Gress TW, Hambuchen MD, et al
     Impact of MRSA polymerase chain reaction (PCR) wound swabs on antibiotic de-escalation in skin and soft tissue infections.
     Diagn Microbiol Infect Dis. 2022;103:115722.
     PubMed     Abstract available
     
     
     
176. ANNE-GAELLE R, Celia S, Jeanne C, Frederic B, et al
     Performances of the BD MAX CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
     Diagn Microbiol Infect Dis. 2022;103:115701.
     PubMed     Abstract available
     
     
     
177. YOO IY, Shin DP, Heo W, Ha SI, et al
     Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs.
     Diagn Microbiol Infect Dis. 2022;103:115716.
     PubMed     Abstract available
     
     
     
178. VAILLANT JJ, Cunningham SA, Patel R
     Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog(R) system, a metabolic phenotyping assay.
     Diagn Microbiol Infect Dis. 2022;104:115759.
     PubMed     Abstract available
     
     
     June 2022
179. KOBAYASHI Y, Shibata S, Yagi T
     Molecular epidemiology and antimicrobial susceptibility profiles of Campylobacter jejuni isolated from bloodstream infections and enteritis in Japan.
     Diagn Microbiol Infect Dis. 2022;103:115681.
     PubMed     Abstract available
     
     
     May 2022
180. CLOSE RM, Sutcliffe CG, Galdun P, Reid A, et al
     Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study.
     Diagn Microbiol Infect Dis. 2022;103:115729.
     PubMed     Abstract available
     
     
     
181. YU HJ, Kim TY, Shim HJ, Yun SA, et al
     Comparison between the STANDARD F S. Pneumoniae Ag FIA and BinaxNOW S. Pneumoniae Antigen Card for Detection of Streptococcus Pneumoniae Urinary Antigen.
     Diagn Microbiol Infect Dis. 2022;104:115725.
     PubMed     Abstract available
     
     
     
182. YAMADA T, Minami K, Oda K, Suzuki K, et al
     Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
     Diagn Microbiol Infect Dis. 2022;103:115662.
     PubMed     Abstract available
     
     
     
183. KHODER M, Rafei R, Osman M, Kassem II, et al
     Emergence of a Neisseria flavescens clinical strain with a high level of third-generation cephalosporins resistance in Lebanon.
     Diagn Microbiol Infect Dis. 2022;103:115660.
     PubMed     Abstract available
     
     
     
184. ZHU X, Zhao Y, Zhu C, Wang Y, et al
     Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay.
     Diagn Microbiol Infect Dis. 2022;103:115661.
     PubMed     Abstract available
     
     
     
185. PIETIKAINEN A, Backman I, Henningsson AJ, Hytonen J, et al
     Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology.
     Diagn Microbiol Infect Dis. 2022;103:115657.
     PubMed     Abstract available
     
     
     April 2022
186. DIENSTHUBER D, Simnacher U, Peters S, Walther P, et al
     Clearing Chlamydia abortus infection in epithelial cells and primary human macrophages by use of antibiotics and the MDM2-p53-inhibitor nutlin-3.
     Diagn Microbiol Infect Dis. 2022;103:115715.
     PubMed     Abstract available
     
     
     
187. AONO A, Murase Y, Chikamatsu K, Igarashi Y, et al
     In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
     Diagn Microbiol Infect Dis. 2022;103:115714.
     PubMed     Abstract available
     
     
     
188. ROSTAMIAN M, Kooti S, Mohammadi B, Salimi Y, et al
     A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect.
     Diagn Microbiol Infect Dis. 2022;102:115634.
     PubMed     Abstract available
     
     
     
189. YOSHIMURA M, Tokushige C, Maruyama JI, Kawano Y, et al
     Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
     Diagn Microbiol Infect Dis. 2022;102:115633.
     PubMed     Abstract available
     
     
     
190. PRINCE HE, Batterman HJ, Realegeno SE, Marlowe EM, et al
     Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
     Diagn Microbiol Infect Dis. 2022;102:115630.
     PubMed     Abstract available
     
     
     
191. PFALLER MA, Carvalhaes CG, DeVries S, Huband MD, et al
     Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
     Diagn Microbiol Infect Dis. 2022;102:115627.
     PubMed     Abstract available
     
     
     March 2022
192. SAVINOVA T, Bocharova Y, Mayanskiy N, Chebotar I, et al
     Genetic determinants of virulence and antibiotic resistance are common for Pseudomonas aeruginosa ST235 isolates from cystic fibrosis patients from various geographical regions.
     Diagn Microbiol Infect Dis. 2022;102:115596.
     PubMed     Abstract available
     
     
     February 2022
193. BOSCHIERO MN, Duarte A, Palamim CVC, Alvarez AE, et al
     Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing.
     Diagn Microbiol Infect Dis. 2022;102:115576.
     PubMed     Abstract available
     
     
     
194. SUN Y, Shukla MR, Deutsch J, Cao W, et al
     Evaluation of the effect of extended refrigerated storage of serum and plasma specimens on syphilis serologic test results.
     Diagn Microbiol Infect Dis. 2022;102:115588.
     PubMed     Abstract available
     
     
     
195. MELENDEZ JH, Chen FE, Wang TH
     Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.
     Diagn Microbiol Infect Dis. 2022;102:115590.
     PubMed     Abstract available
     
     
     
196. ROSSATO L, Arantes JP, Ribeiro SM, Simionatto S, et al
     Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains.
     Diagn Microbiol Infect Dis. 2022;102:115569.
     PubMed     Abstract available
     
     
     January 2022
197. BOLKER A, Coe K, Smith J, Stevenson K, et al
     Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
     Diagn Microbiol Infect Dis. 2022;102:115558.
     PubMed     Abstract available
     
     
     
198. SADER HS, Mendes RE, Streit JM, Carvalhaes CG, et al
     Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
     Diagn Microbiol Infect Dis. 2022;102:115557.
     PubMed     Abstract available
     
     
     
199. WORMSER GP
     A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
     Diagn Microbiol Infect Dis. 2022;102:115572.
     PubMed     Abstract available
     
     
     December 2021
200. MEEX C, Devey A, Defeche J, Bontems S, et al
     Evaluation of the Revogene(R) GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture.
     Diagn Microbiol Infect Dis. 2021;102:115616.
     PubMed     Abstract available
     
     
     
201. DE BENEDETTO I, Boglione L
     Reply to: impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs.
     Diagn Microbiol Infect Dis. 2021;102:115615.
     PubMed    
     
     
     
202. CHOI H, Hwang M, Chatterjee P, Jinadatha C, et al
     Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification.
     Diagn Microbiol Infect Dis. 2021;101:115538.
     PubMed     Abstract available
     
     
     
203. HU S, Lv Z, Wang Y, Shen J, et al
     Novel Quadruplex PCR for detecting and genotyping mobile colistin resistance genes in human samples.
     Diagn Microbiol Infect Dis. 2021;101:115419.
     PubMed     Abstract available
     
     
     
204. BUTCHER M, Puiu D, Romagnoli M, Carroll KC, et al
     Rapidly fatal infection with Bacillus cereus/thuringiensis: genome assembly of the responsible pathogen and consideration of possibly contributing toxins.
     Diagn Microbiol Infect Dis. 2021;101:115534.
     PubMed     Abstract available
     
     
     
205. WOODSON EN, Katz SS, Mosley SS, Danavall DC, et al
     Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).
     Diagn Microbiol Infect Dis. 2021;101:115532.
     PubMed     Abstract available
     
     
     
206. BOUSSI LS, Popli T, Feola N, Nog R, et al
     Clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin.
     Diagn Microbiol Infect Dis. 2021;101:115515.
     PubMed     Abstract available
     
     
     
207. SADEK M, Poirel L, Dominguez Pino M, D'Emidio F, et al
     Evaluation of SuperCAZ/AVI(R) Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.
     Diagn Microbiol Infect Dis. 2021;101:115475.
     PubMed     Abstract available
     
     
     
208. SCANGARELLA-OMAN NE, Dixon P, Koeth LM, DiFranco-Fisher J, et al
     Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.
     Diagn Microbiol Infect Dis. 2021;101:115484.
     PubMed     Abstract available
     
     
     
209. SENCHYNA F, Tamburini FB, Murugesan K, Watz N, et al
     Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam.
     Diagn Microbiol Infect Dis. 2021;101:115511.
     PubMed     Abstract available
     
     
     
210. HOVAN MR, Narayanan N, Cedarbaum V, Bhowmick T, et al
     Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
     Diagn Microbiol Infect Dis. 2021;101:115505.
     PubMed     Abstract available
     
     
     
211. AKAPELWA ML, Kapalamula TF, Ouchi-Aizu Y, Hang'ombe BM, et al
     Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its application.
     Diagn Microbiol Infect Dis. 2021;101:115494.
     PubMed     Abstract available
     
     
     November 2021
212. HEIREMAN L, Bruynseels P, Camps K, Geysels D, et al
     Comparison of the QuantiFERON-TB(R) Gold Plus on LIAISON(R) XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population.
     Diagn Microbiol Infect Dis. 2021;102:115613.
     PubMed     Abstract available
     
     
     
213. LOPEZ-PINTOR JM, Martinez-Garcia L, Maruri A, Menendez B, et al
     Quantification of plasmid copy number as surrogate marker of virulence among different invasive and non-invasive genotypes of Chlamydia trachomatis.
     Diagn Microbiol Infect Dis. 2021;102:115610.
     PubMed     Abstract available
     
     
     
214. MCCREERY R, Nielsen L, Clarey D, Murphy C, et al
     Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire(R) FilmArray(R) Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
     Diagn Microbiol Infect Dis. 2021;102:115605.
     PubMed     Abstract available
     
     
     
215. JIANG X, Zhu L, Zhan D
     Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples.
     Diagn Microbiol Infect Dis. 2021;102:115594.
     PubMed     Abstract available
     
     
     
216. ZAMORA-CINTAS MI, Lopez DJ, Blanco AC, Rodriguez TM, et al
     Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
     Diagn Microbiol Infect Dis. 2021;101:115416.
     PubMed     Abstract available
     
     
     
217. NOVY E, Goury A, Thivilier C, Guillard T, et al
     Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients.
     Diagn Microbiol Infect Dis. 2021;101:115507.
     PubMed     Abstract available
     
     
     
218. RUIZ-BASTIAN M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, et al
     Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave.
     Diagn Microbiol Infect Dis. 2021;101:115477.
     PubMed     Abstract available
     
     
     
219. TIMBROOK TT, Hueth KD, Ginocchio CC
     Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire(R) FilmArray(R) pneumonia panel: a systematic review and meta-analysis.
     Diagn Microbiol Infect Dis. 2021;101:115476.
     PubMed     Abstract available
     
     
     
220. UGABAN KB, She RC
     The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center.
     Diagn Microbiol Infect Dis. 2021;102:115592.
     PubMed     Abstract available
     
     
     
221. YONETANI S, Hirao C, Ohnishi H
     Background of patients with Aerococcus spp. detected in blood cultures, and drug sensitivity of Aerococcus spp.
     Diagn Microbiol Infect Dis. 2021;101:115506.
     PubMed     Abstract available
     
     
     
222. DIEZ A, Carrano G, Bregon-Villahoz M, Cuetara MS, et al
     Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
     Diagn Microbiol Infect Dis. 2021;101:115509.
     PubMed     Abstract available
     
     
     
223. RUSSELLO G, Moramarco A, Vizzini L, Farina C, et al
     Diagnostic approach and epidemiology of Microbial Keratitis: findings from an Italian Tertiary Care center.
     Diagn Microbiol Infect Dis. 2021;101:115470.
     PubMed     Abstract available
     
     
     
224. PFALLER MA, Carvalhaes CG, Messer SA, Rhomberg PR, et al
     In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
     Diagn Microbiol Infect Dis. 2021;101:115473.
     PubMed     Abstract available
     
     
     
225. VALIATTI TB, Santos FF, Nunes PHS, Cayo R, et al
     Characterization of virulent Klebsiella variicola recovered from inpatients with intestinal and extraintestinal infections between 1987 and 1999.
     Diagn Microbiol Infect Dis. 2021;101:115482.
     PubMed    
     
     
     
226. PHILLIPS TR, Tabesh M, Fairley CK, Maddaford K, et al
     A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples.
     Diagn Microbiol Infect Dis. 2021;101:115455.
     PubMed     Abstract available
     
     
     
227. LIN BB, Pattle N, Kelley P, Jaksic AS, et al
     Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature.
     Diagn Microbiol Infect Dis. 2021;101:115413.
     PubMed     Abstract available
     
     
     October 2021
228. MORRISON AR, Jones MC, Makowski CT, Samuel LP, et al
     Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis.
     Diagn Microbiol Infect Dis. 2021;102:115571.
     PubMed     Abstract available
     
     
     
229. QUIRINO A, Marascio N, Peronace C, Gallo L, et al
     Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes.
     Diagn Microbiol Infect Dis. 2021;101:115485.
     PubMed     Abstract available
     
     
     
230. JOSHI P, Shrivastava R, Bhagwat S, Patel M, et al
     Activity of beta-lactam plus beta-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
     Diagn Microbiol Infect Dis. 2021;101:115481.
     PubMed     Abstract available
     
     
     
231. MALCZYNSKI M, Zhu A, Zembower T, Qi C, et al
     Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources.
     Diagn Microbiol Infect Dis. 2021;101:115451.
     PubMed     Abstract available
     
     
     
232. JOHNSTON MM, Huang V, Hall ST, Buckley MS, et al
     Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
     Diagn Microbiol Infect Dis. 2021;101:115442.
     PubMed     Abstract available
     
     
     
233. GOLDEN AR, Fear T, Baxter M, Adam HJ, et al
     Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
     Diagn Microbiol Infect Dis. 2021;101:115447.
     PubMed     Abstract available
     
     
     
234. PARMELAND L, Bourru T, Kyungu V, Rousseau N, et al
     A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
     Diagn Microbiol Infect Dis. 2021;101:115428.
     PubMed     Abstract available
     
     
     
235. NOVAL M, Heil EL, Williams P, Johnson JK, et al
     The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections.
     Diagn Microbiol Infect Dis. 2021;101:115483.
     PubMed     Abstract available
     
     
     
236. WORMSER GP, Strle F, Shapiro ED, Auwaerter PG, et al
     Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020.
     Diagn Microbiol Infect Dis. 2021;101:115446.
     PubMed    
     
     
     
237. CLEMMONS AB, Young HN, Bland CM, Jackson B, et al
     Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia.
     Diagn Microbiol Infect Dis. 2021;101:115444.
     PubMed     Abstract available
     
     
     September 2021
238. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
     Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria.
     Diagn Microbiol Infect Dis. 2021;102:115556.
     PubMed     Abstract available
     
     
     
239. GARCIA-CABALLERO A, de Dios Caballero J, Maruri A, Serrano-Tomas MI, et al
     Evaluation of different phenotypic methods to detect methicillin resistance in Staphylococcus aureus isolates recovered from cystic fibrosis patients.
     Diagn Microbiol Infect Dis. 2021;102:115559.
     PubMed     Abstract available
     
     
     
240. XIA XJ, Zhong Y, Sang B, Li QP, et al
     Violet colonies of Talaromyces marneffei produce on CHROMagar candida medium.
     Diagn Microbiol Infect Dis. 2021;101:115533.
     PubMed     Abstract available
     
     
     
241. KUFEL WD, Mastro KA, Steele JM, Wang D, et al
     Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
     Diagn Microbiol Infect Dis. 2021;101:115535.
     PubMed     Abstract available
     
     
     
242. ROSALES-REYES R, Esposito F, Fontana H, Lezana-Fernandez JL, et al
     Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
     Diagn Microbiol Infect Dis. 2021;101:115454.
     PubMed     Abstract available
     
     
     
243. ITO A, Ishida T, Tachibana H, Nakanishi Y, et al
     Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study.
     Diagn Microbiol Infect Dis. 2021;101:115457.
     PubMed     Abstract available
     
     
     
244. VAN DEN MUNCKHOF EHA, van Sitter RL, Lamont RF, le Cessie S, et al
     Developing an algorithm for the diagnosis of abnormal vaginal discharge in a dutch clinical setting: a pilot study.
     Diagn Microbiol Infect Dis. 2021;101:115431.
     PubMed     Abstract available
     
     
     
245. WORMSER GP
     Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections.
     Diagn Microbiol Infect Dis. 2021;101:115429.
     PubMed     Abstract available
     
     
     
246. MAHAJAN N, Sood S, Das BK, Kapil A, et al
     Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India.
     Diagn Microbiol Infect Dis. 2021;101:115423.
     PubMed     Abstract available
     
     
     
247. TICKLER IA, Shettima SA, Dela Cruz CM, Le VM, et al
     Characterization of carbapenem-resistant gram-negative bacterial isolates from Nigeria by whole genome sequencing.
     Diagn Microbiol Infect Dis. 2021;101:115422.
     PubMed     Abstract available
     
     
     
248. WALKTY A, Karlowsky JA, Baxter MR, Adam HJ, et al
     In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.
     Diagn Microbiol Infect Dis. 2021;101:115418.
     PubMed     Abstract available
     
     
     
249. KRISTOF K, Adamkova V, Adler A, Gospodarek-Komkowska E, et al
     In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018.
     Diagn Microbiol Infect Dis. 2021;101:115420.
     PubMed     Abstract available
     
     
     
250. SONG J, Kim S, Park J, Park Y, et al
     Comparison of two beta-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
     Diagn Microbiol Infect Dis. 2021;101:115415.
     PubMed     Abstract available
     
     
     August 2021
251. ZHANG CY, Zhang HH, Zhao SL, Wu HY, et al
     Clinical value of alkaline phosphatase on the surface membrane of neutrophils for prediction of bacteremia in patients with systemic inflammatory response syndrome.
     Diagn Microbiol Infect Dis. 2021;100:114105.
     PubMed     Abstract available
     
     
     
252. BIBBOLINO G, Di Lella FM, Oliva A, Lichtner M, et al
     Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019.
     Diagn Microbiol Infect Dis. 2021;100:115399.
     PubMed     Abstract available
     
     
     
253. CLAY TB, Orwig KW, Stevens RA, Davis EP, et al
     Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections.
     Diagn Microbiol Infect Dis. 2021;100:115389.
     PubMed     Abstract available
     
     
     July 2021
254. SAPOZHNIKOV J, Huang A, Zeeck K, Gibble A, et al
     Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents.
     Diagn Microbiol Infect Dis. 2021;101:115472.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.